CrushSCI.com
135.8平均天数
115中位天数
95最短天数
196最长天数
5992025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

95 天

Alterations in Epoxyeicosatrienoic Acids Metabolism in Type 2 Diabetes Mellitus and Potential Association with Retinopathy Progression

作者
İsmail Sarı; Esma Özmen; Kürşad Ramazan Zor; Serpil Erşan; Erkut Küçük; Durmuş Ayan; İsmail Abasıkeleş展开收起
作者单位
1. Department of Medical Biochemistry, Faculty of Medicine, Kırklareli University, Kırklareli, 39100, Türkiye;; 2. Department of Medical Biochemistry, Faculty of Medicine, Nigde Omer Halisdemir University, Niğde, 51240, Türkiye;; 3. Department of Ophthalmology, Faculty of Medicine, Nigde Omer Halisdemir University, Niğde, 51240, Türkiye;; 4. Department of Internal Medicine, Nigde Omer Halisdemir Education and Research Hospital, Niğde, Türkiye展开收起
官方全文证据 DOI 网页
178 天

Uncovering Shared Diagnostic Genes and Mechanisms in Chronic Kidney Disease and Atherosclerosis: A Bioinformatics Approach

作者
Hua Li; Jinfeng Guo; Hao Luo; Rui Huang; Hongwei Su展开收起
作者单位
1. College of Integrated Traditional and Western Medicine, Southwest Medical University, Luzhou, 646000, China;; 2. Department of Urology, The Affiliated Traditional Medicine Hospital, Southwest Medical University, Luzhou, 646000, China展开收起
官方全文证据 DOI 网页
95 天

Apoptosis, Pyroptosis, and Necroptosis (PANoptosis) may be Present in Renal Ischemic Injury

作者
Lewen Wang; Shuang Lu; Dongsheng Zhao; Guoqian Hu; Guijiang Tang; Kun Xiong; Jin Tang; Weitao Yan展开收起
作者单位
1. Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, China;; 2. Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, Hunan, 410013, China;; 3. The Key Laboratory of Brain Science Research & Transformation in Tropical Environment of Hainan Province, Hainan Medical University, Haikou, Hainan 571199, China展开收起
官方全文证据 DOI 网页
196 天

Inhibition of Circular RNA 006029 Alleviates Pancreatic β-Cell Injury Through the AKT/mTOR Signaling Pathway

作者
Zhen Wang; Zheli Luo; Li Wang; Jiaxing Feng; Kunlin Huang; Ying Zheng; Zhiguang Zhou展开收起
作者单位
1. Department of Metabolism and Endocrinology, Guilin Hospital of the Second Xiangya Hospital CSU, Guilin, 541100, China;; 2. Key Laboratory of Diabetes Immunology, Department of Metabolism and Endocrinology, National Clinical Research Center for Endocrine and Metabolic Diseases, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, 410011, China;; 3. Department of Endocrinology, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, China;; 4. Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China;; 5. Center for Medical Research, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China展开收起
官方全文证据 DOI 网页
115 天

Ubiquitination-based Classification and a Prognostic Signature Identify the Role of TRIM21 in Sarcoma Progression

作者
Lin Zhang; Weihao Lin; Jinhui Liu; Yuheng Hong; Zheng Cao; Zhentao Yu; Xiaoli Feng; Yibo Gao展开收起
作者单位
1. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China;; 2. Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China;; 3. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China;; 4. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China;; 5. Central Laboratory & Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China;; 6. Laboratory of Thoracic Oncology & Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China;; 7. State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China;; 8. Laboratory of Translational Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China展开收起
官方全文证据 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。